How should rabies immune globulin (RIG) be administered after a potential rabies exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Administer Rabies Immunoglobulin

Infiltrate the full calculated dose (20 IU/kg body weight) of rabies immune globulin directly into and around all wounds as anatomically feasible, then inject any remaining volume intramuscularly at a site distant from the vaccine administration. 1

Dosing

  • Calculate dose: 20 IU/kg (0.133 mL/kg) body weight for all age groups, including children 1
  • Never exceed the recommended dose - excess RIG can suppress active antibody production from the vaccine 1

Administration Technique

Wound Infiltration (Primary Route)

  • Thoroughly infiltrate the full calculated dose into and around all wounds whenever anatomically feasible 1
  • This local infiltration is critical - rare PEP failures have been documented when insufficient RIG was infiltrated at exposure sites 1
  • Volume requirements vary by wound size: approximately 1 mL for wounds <1 cm, 3 mL for 1-5 cm wounds, and 5 mL for wounds >5 cm 2

Remaining Volume

  • Inject any remaining RIG volume intramuscularly at a site distant from vaccine administration 1
  • Common IM sites include the gluteal region or thigh

Critical Timing Rules

  • Administer RIG only once - give at the beginning of PEP (day 0) with the first vaccine dose 1
  • If missed on day 0: RIG can still be given up to and including day 7 of the vaccine series 1
  • After day 7: Do NOT give RIG - active antibody response to vaccine is presumed to have occurred by this point 1

Key Administration Prohibitions

  • Never administer RIG in the same syringe as vaccine 1
  • Never administer RIG in the same anatomical site as the first vaccine dose 1
  • Note: Subsequent vaccine doses (days 3,7,14,28) can be given in the same anatomic location where RIG was administered 1

Who Should NOT Receive RIG

Do not give RIG to previously vaccinated persons who have:

  • Completed a pre-exposure or post-exposure vaccination regimen with cell culture vaccine, OR
  • Documented rabies virus neutralizing antibody titer from prior vaccination 1

These individuals receive vaccine only for post-exposure prophylaxis.

Common Pitfalls

Real-world adherence data reveals a critical gap: While healthcare systems demonstrate excellent adherence to patient selection (91%), dosing (98%), and timing (100%), only 56% of eligible patients actually receive proper wound infiltration 3. This represents a significant clinical failure point, as wound infiltration is specifically recommended based on documented PEP failures when inadequate RIG was infiltrated locally 1.

Delayed administration is common: Studies show mean delays of 8.7 days for RIG administration, particularly for exposures occurring abroad (9.6 days vs 6 days for domestic exposures) 4. Despite these delays, if within 7 days, still administer the RIG.

Essential Concurrent Measures

Before RIG administration:

  • Thoroughly wash all wounds immediately with soap and copious water for approximately 15 minutes 1, 5
  • Apply viricidal agent (iodine-containing preparation) when available 5
  • Wound cleansing alone markedly reduces rabies likelihood in animal studies 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.